Royal Bank of Canada’s Revolution Medicines RVMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17M | Buy |
86,171
+83,746
| +3,453% | +$3.08M | ﹤0.01% | 2681 |
|
|
2025
Q1 | $86K | Sell |
2,425
-9,401
| -79% | -$333K | ﹤0.01% | 4957 |
|
|
2024
Q4 | $518K | Sell |
11,826
-18,114
| -61% | -$793K | ﹤0.01% | 3638 |
|
|
2024
Q3 | $1.36M | Buy |
29,940
+13,343
| +80% | +$605K | ﹤0.01% | 2925 |
|
|
2024
Q2 | $644K | Buy |
16,597
+10,206
| +160% | +$396K | ﹤0.01% | 3460 |
|
|
2024
Q1 | $205K | Sell |
6,391
-39,172
| -86% | -$1.26M | ﹤0.01% | 4242 |
|
|
2023
Q4 | $1.31M | Buy |
45,563
+30,664
| +206% | +$880K | ﹤0.01% | 2992 |
|
|
2023
Q3 | $413K | Buy |
14,899
+6,404
| +75% | +$178K | ﹤0.01% | 3742 |
|
|
2023
Q2 | $227K | Buy |
8,495
+3,392
| +66% | +$90.6K | ﹤0.01% | 4212 |
|
|
2023
Q1 | $110K | Sell |
5,103
-4,715
| -48% | -$102K | ﹤0.01% | 4733 |
|
|
2022
Q4 | $234K | Buy |
9,818
+8,710
| +786% | +$208K | ﹤0.01% | 4290 |
|
|
2022
Q3 | $22K | Buy |
1,108
+553
| +100% | +$11K | ﹤0.01% | 5614 |
|
|
2022
Q2 | $11K | Sell |
555
-3,295
| -86% | -$65.3K | ﹤0.01% | 5886 |
|
|
2022
Q1 | $98K | Buy |
3,850
+530
| +16% | +$13.5K | ﹤0.01% | 5185 |
|
|
2021
Q4 | $84K | Buy |
3,320
+1,565
| +89% | +$39.6K | ﹤0.01% | 5531 |
|
|
2021
Q3 | $48K | Buy |
+1,755
| New | +$48K | ﹤0.01% | 5672 |
|
|
2021
Q2 | – | Sell |
-2,994
| Closed | -$137K | – | 7045 |
|
|
2021
Q1 | $137K | Buy |
2,994
+2,498
| +504% | +$114K | ﹤0.01% | 4747 |
|
|
2020
Q4 | $20K | Buy |
496
+466
| +1,553% | +$18.8K | ﹤0.01% | 5519 |
|
|
2020
Q3 | $1K | Buy |
30
+5
| +20% | +$167 | ﹤0.01% | 5975 |
|
|
2020
Q2 | $1K | Sell |
25
-683
| -96% | -$27.3K | ﹤0.01% | 5995 |
|
|
2020
Q1 | $15K | Buy |
+708
| New | +$15K | ﹤0.01% | 5178 |
|